Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment

Xiao-Xiao Fu1 Institute of Anatomy and Sir Run Run Shaw Hospital, Medical College, Zhejiang University, Hangzhou, People’s Republic of ChinaView further author information

Jin Wang1 Institute of Anatomy and Sir Run Run Shaw Hospital, Medical College, Zhejiang University, Hangzhou, People’s Republic of China

https://orcid.org/0000-0002-3840-4778 View further author information

Hua-Ying Cai1 Institute of Anatomy and Sir Run Run Shaw Hospital, Medical College, Zhejiang University, Hangzhou, People’s Republic of ChinaView further author information

Hong Jiang1 Institute of Anatomy and Sir Run Run Shaw Hospital, Medical College, Zhejiang University, Hangzhou, People’s Republic of ChinaView further author information

Jin-Zhan Jiang2 Medical Molecular Biology Laboratory, School of Medicine, Jinhua Polytechnic, Jinhua, People’s Republic of ChinaView further author information

Hao-Hao Chen2 Medical Molecular Biology Laboratory, School of Medicine, Jinhua Polytechnic, Jinhua, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Shu Han1 Institute of Anatomy and Sir Run Run Shaw Hospital, Medical College, Zhejiang University, Hangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information

show all

Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date